Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problem
- PMID: 15505274
- DOI: 10.1200/JCO.2004.07.961
Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problem
Erratum in
- J Clin Oncol. 2005 Jan 1;23(1):248
Comment on
-
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.J Clin Oncol. 2004 Dec 1;22(23):4622-30. doi: 10.1200/JCO.2004.02.145. Epub 2004 Oct 25. J Clin Oncol. 2004. PMID: 15505276 Clinical Trial.
Similar articles
-
Breast cancer: metastatic.Clin Evid. 2002 Jun;(7):1579-602. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):1785-810. PMID: 12230774 Updated. Review. No abstract available.
-
The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.J Clin Oncol. 2005 Sep 20;23(27):6807-9. doi: 10.1200/JCO.2005.02.3952. J Clin Oncol. 2005. PMID: 16170197 No abstract available.
-
Adjuvant treatment of breast cancer.R I Med. 1995 Sep;78(9):250-3. R I Med. 1995. PMID: 7579720 Review. No abstract available.
-
Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?Breast Cancer Res Treat. 2005 Nov;94(2):95-103. doi: 10.1007/s10549-004-8267-0. Breast Cancer Res Treat. 2005. PMID: 16261407
-
Ovarian ablation as adjuvant therapy for early-stage breast cancer.Cancer Treat Res. 1998;94:158-80. Cancer Treat Res. 1998. PMID: 9587687 Review. No abstract available.
Cited by
-
WP1130 increases cisplatin sensitivity through inhibition of usp9x in estrogen receptor-negative breast cancer cells.Am J Transl Res. 2017 Apr 15;9(4):1783-1791. eCollection 2017. Am J Transl Res. 2017. PMID: 28469783 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical